GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Fri, 19 Apr 2024

Trading levels for APVO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.81 5.54 %
R2 0.788 2.37 %
R1 0.773 0.405 %
Current price: 0.770
Support S1 0.724 -5.95 %
S2 0.709 -7.91 %
S3 0.685 -11.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.96 24.42 %
R2 0.85 9.75 %
R1 0.783 1.69 %
Current price 0.770
Support S1 0.768 -0.260%
S2 0.713 -7.47%
S3 0 .

APVO Predictions History

3 years ago
sander7100 yo bro predicted that APVO for 2020-07-22 is going $6.53 (-20.27%)

3 years ago
JS predicted that APVO for 2020-07-22 is going $7.75 (-5.37%)

3 years ago
iHustle84 predicted that APVO for 2020-07-22 is going $8.00 (-2.32%)

3 years ago
Yusuke predicted that APVO for 2020-07-22 is going $11.00 (34.64%)

Rank:

4 years ago
NameNotImportant predicted that APVO for 2019-05-06 is going $0.89 (22.15%)

4 years ago
NameNotImportant predicted that APVO for 2019-05-03 is going $0.707 (-2.96%)

Click to get the best stock tips daily for free!

About Aptevo Therapeutics Inc

Aptevo Therapeutics Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational ... APVO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT